source
- Top FDA gene and cell therapy regulator to step downFollowing Vijay Kumar’s exit, acting CBER Director Karim Mikhail will also oversee a review office that has become a battleground for debates on FDA flexibility.BioPharma Dive · 28d ago↗ source
- STAT+: Investors double down on Bain-backed startupFDA's top gene therapy regulator steps down, Trump's plan to lower GLP-1 prices, and more biotech newsSTAT · 28d ago↗ source
- STAT+: FDA digital leader hints at coming AI policy updatesToday's health tech news includes virtual PT for a whole country, what the FDA is considering on AI policy, and moreSTAT · 28d ago↗ source